http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112574283-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B30-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1037 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 |
| filingDate | 2020-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112574283-B |
| titleOfInvention | A kind of human MUC1 specific binding polypeptide and its extraction method |
| abstract | The invention discloses a human MUCl specific binding polypeptide, the amino acid sequence of which is HKFIPHRDTSIA. The polypeptide is verified by methods such as biopanning, amplification of positive phage, DNA sequence determination of the polypeptide encoded by the phage, and ELISA assay on the screened positive phage. The polypeptide has small molecular weight, easy chemical synthesis, low immunogenicity, can specifically bind to human MUC1 protein, and has good application value in the field of tumor diagnosis and treatment targeting human MUC1 protein. |
| priorityDate | 2020-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.